Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heritage Global is a diversified financial services company that specializes in asset liquidation, valuation, and advisory services, with a significant focus on the life sciences and technology sectors. Through its subsidiary, Heritage Global Partners, the company facilitates the sale of surplus laboratory, R&D, and manufacturing equipment for major pharmaceutical and biotechnology organizations globally. It operates a sophisticated online auction platform that connects sellers of high-value scientific assets with a global network of buyers. By providing transparency and market-driven pricing for secondary market equipment, Heritage Global plays a critical role in the capital lifecycle of biotech firms. The company is publicly traded on the NASDAQ under the symbol HGBL and is headquartered in San Diego, California.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heritage Global.